An aggressive sales posture is not a matter of individual character or deviance. It is the structure of revenue targets handed down from above that tilts even conscientious staff forward. This piece traces why top-line pressure quietly pulls the wording of field materials, working from the dynamics of disclosure rules and target management.
01Where the Pressure Is Born, and Where It Flows
A listed company is bound by the earnings guidance it has published itself and by quarterly disclosure. Missing the top line — revenue — pushes the share price down and strikes directly at how the executives themselves are judged. The appropriate disclosure called for by Basic Principle 3 of Japan's Corporate Governance Code means, seen from the other side, being confronted every quarter with the numbers promised to the market.
This pressure does not stop at the top of the organization. Company-wide targets are broken down into divisional targets, and divisional targets into individual ones, almost mechanically. The further downstream you go, the less room there is to escape. A single line of figures spoken in a management meeting lands on the floor as each person's attainment rate. Sales leaning forward is a phenomenon that occurs at the end of this path.
02Three Mechanisms That Produce the Forward Lean
Why is it that the more conscientious the representative, the greater the urge to embellish? Locating the cause in individual ethics alone leads to the wrong remedy. The forward lean is the result of the following three mechanisms operating in series, from upstream to downstream.
Pressure from the disclosure regime
Earnings guidance and quarterly disclosure confront management every period with the numbers promised to the market. Because a shortfall rebounds onto the share price and executive evaluations, the pressure to deliver is born first at the top.
The cascade of targets
Company-wide targets are broken down mechanically to divisions and individuals. Once attainment is tied directly to pay and appraisal, materials are quietly pulled toward "looking more effective."
Asymmetry of time horizons
Revenue becomes visible quickly, but the cost of a violation arrives late and on a far larger scale. The shorter management's time horizon, the more near-term numbers take priority over future risk.
The three do not move separately; they are connected along a single line. An exaggerated claim is the red lamp that lights at the end of this wiring, and smashing the lamp does not change the wiring itself. A single rejection, therefore, treats no more than the symptom.
03The Asymmetry of Time Horizons — Profit Comes Early, the Cost of Violation Comes Late
The third mechanism bears down especially hard in pharmaceuticals. The fruit of revenue shows up as a figure within the quarter. The cost of a violation — surcharges, suspension of shipment, and the loss of trust — appears later, after investigation and sanction, and on a scale orders of magnitude larger. Between the fruit and the invoice lies a long lag.
The balance between capital efficiency and medium-to-long-term investment discussed in the Ito Review is this asymmetry restated in the language of management. The more you optimize for the short-term top line, the larger the invoice you pay over the medium and long term. The lag between profit that looks fast and loss that arrives late is what clouds judgment. This is less a matter of individual weakness than a tilt common to people and organizations alike — the tendency to discount future losses when we look at them.
04To the Materials-Review Floor — Exaggeration Is a Symptom of Structure
So what should a reviewer look at when facing this structure? When a piece of material that ought to be sent back is in front of you, what you are dealing with is not a "deviant individual" but rational behavior under heavy pressure. Only by reframing it this way does the axis of the conversation shift from hunting for a culprit to proposing changes to the structure.
The deviation cases listed in the MHLW's monitoring project report on promotional information activities, though company names are withheld, reflect the same tilt. Fixing a single exaggeration only means the same mechanism will light the same lamp on the next piece of material. So a reviewer wants to bring within range not only the wording in front of them but the target design behind it and how it feeds pay and appraisal (The Board's View, Vol. 5 — Nomination and Compensation Committees). Revenue and compliance may look opposed in the short term, yet over the long term they are integrated (this series, Vol. 7 — Profit and Compliance). A reviewer who can hold that perspective is relied on by management not as a brake that only stops, but as a steering wheel that points a direction.
- The source of revenue pressure is quarterly disclosure and earnings guidance. The numbers promised to the market come down from management to the floor as an obligation to deliver every period.
- Company-wide targets are broken down (cascaded) mechanically to divisions and individuals; the more tightly attainment is tied to pay, the more materials are pulled toward "looking effective."
- Profit becomes visible early; the cost of a violation appears late and large. This asymmetry of time horizons produces the tilt toward short-term optimization.
- Exaggeration is not a representative running wild but a symptom of target design. Review faces it not as a hunt for a culprit but as a proposal addressed to the structure.
- Tokyo Stock Exchange. Corporate Governance Code, Basic Principle 3 (Ensuring Appropriate Information Disclosure and Transparency). Provides that listed companies should appropriately disclose financial information, management strategy, and the like.
- Ministry of Economy, Trade and Industry (METI). Final Report of the "Competitiveness and Incentives for Sustainable Growth: Building Favorable Relationships between Companies and Investors" Project (Ito Review, 2014). Discusses the balance between capital efficiency and medium-to-long-term investment, and the harms of short-termism.
- Ministry of Health, Labour and Welfare (MHLW). Report on the Monitoring Project for Promotional Information Activities for Prescription Drugs. Shows trends in cases that deviate from advertising regulation (company names anonymized).